Boehringer to Acquire Manufacturing Facility From Amgen

Boehringer Ingelheim GmbH, a German pharmaceutical company, has signed an agreement to acquire Amgen, Inc.’s rights in substantially all assets at its Fremont, California development and manufacturing facility.
TradingMarkets